Literature DB >> 29127543

Self-efficacy, pain, and quadriceps capacity at baseline predict changes in mobility performance over 2 years in women with knee osteoarthritis.

Nicholas M Brisson1, Anthony A Gatti1, Paul W Stratford1, Monica R Maly2,3.   

Abstract

This study examined the extent to which baseline measures of quadriceps strength, quadriceps power, knee pain and self-efficacy for functional tasks, and their interactions, predicted 2-year changes in mobility performance (walking, stair ascent, stair descent) in women with knee osteoarthritis. We hypothesized that lesser strength, power and self-efficacy, and higher pain at baseline would each be independently associated with reduced mobility over 2 years, and each of pain and self-efficacy would interact with strength and power in predicting 2-year change in stair-climbing performance. This was a longitudinal, observational study of women with clinical knee osteoarthritis. At baseline and follow-up, mobility was assessed with the Six-Minute Walk Test, and stair ascent and descent tasks. Quadriceps strength and power, knee pain, and self-efficacy for functional tasks were also collected at baseline. Multiple linear regression examined the extent to which 2-year changes in mobility performances were predicted by baseline strength, power, pain, and self-efficacy, after adjusting for covariates. Data were analyzed for 37 women with knee osteoarthritis over 2 years. Lower baseline self-efficacy predicted decreased walking (β = 1.783; p = 0.030) and stair ascent (β = -0.054; p < 0.001) performances over 2 years. Higher baseline pain intensity/frequency predicted decreased walking performance (β = 1.526; p = 0.002). Lower quadriceps strength (β = 0.051; p = 0.015) and power (β = 0.022; p = 0.022) interacted with lesser self-efficacy to predict worsening stair ascent performance. Strategies to sustain or improve mobility in women with knee osteoarthritis must focus on controlling pain and boosting self-efficacy. In those with worse self-efficacy, developing knee muscle capacity is an important target.

Entities:  

Keywords:  Muscle power; Muscle strength; Osteoarthritis, knee; Patient-reported outcomes; Stair climbing; Walking

Mesh:

Year:  2017        PMID: 29127543     DOI: 10.1007/s10067-017-3903-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  41 in total

1.  Fixed-flexion radiography of the knee provides reproducible joint space width measurements in osteoarthritis.

Authors:  Manish Kothari; Ali Guermazi; Gabriele von Ingersleben; Yves Miaux; Martine Sieffert; Jon E Block; Randall Stevens; Charles G Peterfy
Journal:  Eur Radiol       Date:  2004-05-19       Impact factor: 5.315

2.  Quadriceps weakness predicts risk for knee joint space narrowing in women in the MOST cohort.

Authors:  N A Segal; N A Glass; J Torner; M Yang; D T Felson; L Sharma; M Nevitt; C E Lewis
Journal:  Osteoarthritis Cartilage       Date:  2010-02-11       Impact factor: 6.576

Review 3.  Course of functional status and pain in osteoarthritis of the hip or knee: a systematic review of the literature.

Authors:  Gabriella M van Dijk; Joost Dekker; Cindy Veenhof; Cornelia H M van den Ende
Journal:  Arthritis Rheum       Date:  2006-10-15

4.  An integrated biomechanical analysis of normal stair ascent and descent.

Authors:  B J McFadyen; D A Winter
Journal:  J Biomech       Date:  1988       Impact factor: 2.712

5.  Intermittent and constant pain and physical function or performance in men and women with knee osteoarthritis: data from the osteoarthritis initiative.

Authors:  Michael J Davison; George Ioannidis; Monica R Maly; Jonathan D Adachi; Karen A Beattie
Journal:  Clin Rheumatol       Date:  2014-11-08       Impact factor: 2.980

6.  Identifying common trajectories of joint space narrowing over two years in knee osteoarthritis.

Authors:  Susan J Bartlett; Shari M Ling; Nancy E Mayo; Susan C Scott; Clifton O Bingham
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-12       Impact factor: 4.794

Review 7.  Quadriceps arthrogenic muscle inhibition: neural mechanisms and treatment perspectives.

Authors:  David Andrew Rice; Peter John McNair
Journal:  Semin Arthritis Rheum       Date:  2009-12-02       Impact factor: 5.532

8.  The course of limitations in activities over 5 years in patients with knee and hip osteoarthritis with moderate functional limitations: risk factors for future functional decline.

Authors:  M F Pisters; C Veenhof; G M van Dijk; M W Heymans; J W R Twisk; J Dekker
Journal:  Osteoarthritis Cartilage       Date:  2012-02-10       Impact factor: 6.576

Review 9.  Risk factors for functional decline in osteoarthritis of the hip or knee.

Authors:  Joost Dekker; Gabriella M van Dijk; Cindy Veenhof
Journal:  Curr Opin Rheumatol       Date:  2009-09       Impact factor: 5.006

10.  Assessing stability and change of four performance measures: a longitudinal study evaluating outcome following total hip and knee arthroplasty.

Authors:  Deborah M Kennedy; Paul W Stratford; Jean Wessel; Jeffrey D Gollish; Dianne Penney
Journal:  BMC Musculoskelet Disord       Date:  2005-01-28       Impact factor: 2.362

View more
  3 in total

1.  Somatosensory and Motor Differences between Physically Active Patients with Chronic Low Back Pain and Asymptomatic Individuals.

Authors:  Juan Nieto-García; Luis Suso-Martí; Roy La Touche; Mónica Grande-Alonso
Journal:  Medicina (Kaunas)       Date:  2019-08-23       Impact factor: 2.430

2.  Effects of self-management education programmes on self-efficacy for osteoarthritis of the knee: a systematic review of randomised controlled trials.

Authors:  Daisuke Uritani; Hitoshi Koda; Sho Sugita
Journal:  BMC Musculoskelet Disord       Date:  2021-06-05       Impact factor: 2.362

3.  High self-efficacy - a predictor of reduced pain and higher levels of physical activity among patients with osteoarthritis: an observational study.

Authors:  Åsa Degerstedt; Hassan Alinaghizadeh; Carina A Thorstensson; Christina B Olsson
Journal:  BMC Musculoskelet Disord       Date:  2020-06-13       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.